2017
DOI: 10.3390/nu9030195
|View full text |Cite
|
Sign up to set email alerts
|

Bifidobacterium bifidum OLB6378 Simultaneously Enhances Systemic and Mucosal Humoral Immunity in Low Birth Weight Infants: A Non-Randomized Study

Abstract: Probiotic supplementation has been part of the discussion on methods to enhance humoral immunity. Administration of Bifidobacterium bifidum OLB6378 (OLB6378) reduced the incidence of late-onset sepsis in infants. In this non-randomized study, we aimed to determine the effect of administration of live OLB6378 on infants’ humoral immunity. Secondly, we tried to elucidate whether similar effects would be observed with administration of non-live OLB6378. Low birth weight (LBW) infants weighing 1500–2500 g were div… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

6
18
0

Year Published

2017
2017
2024
2024

Publication Types

Select...
7
2

Relationship

1
8

Authors

Journals

citations
Cited by 22 publications
(24 citation statements)
references
References 33 publications
6
18
0
Order By: Relevance
“…The correlation analysis showed that the relative abundances of Lachnospiraceae_XPB1014_group, Rikenellaceae_RC9_gut_group, Ruminococcaceae_UCG-002 and Prevotella_2 were negatively correlated with serum IgG content; the lower abundances of these genera triggered by CPB addition indicated that CPB was able to increase host immunity, corresponding with the high serum IgG concentration caused by CPB administration. The previous report showed that probiotics could increase host serum IgG levels [30,31], in agreement with this study. This study demonstrated that oral administration of CPB enhanced host intestinal homeostasis by modulating the composition of gut microbiota for improving piglet production performance.…”
Section: Discussionsupporting
confidence: 93%
“…The correlation analysis showed that the relative abundances of Lachnospiraceae_XPB1014_group, Rikenellaceae_RC9_gut_group, Ruminococcaceae_UCG-002 and Prevotella_2 were negatively correlated with serum IgG content; the lower abundances of these genera triggered by CPB addition indicated that CPB was able to increase host immunity, corresponding with the high serum IgG concentration caused by CPB administration. The previous report showed that probiotics could increase host serum IgG levels [30,31], in agreement with this study. This study demonstrated that oral administration of CPB enhanced host intestinal homeostasis by modulating the composition of gut microbiota for improving piglet production performance.…”
Section: Discussionsupporting
confidence: 93%
“…These data revealed that oral administration of L. frumenti contributes to the intestinal mucosal immunity performed by sIgA and anti-infection immunity performed by IgG and antiviral immunity performed by IFN-γ. Recent evidences have demonstrated that some probiotics [including L. casei ( Ogawa et al, 2001 ; Galdeano and Perdigon, 2006 ), Bifidobacterium animalis ( Martins et al, 2009 ), Bifidobacterium bifidum , Bifidobacterium infantis ( Qiao et al, 2002 ), Bifidobacterium lactis ( Shu and Gill, 2001 ), L. helveticus ( Leblanc et al, 2004 ), Saccharomyces boulardii ( Rodrigues et al, 2000 ; Qamar et al, 2001 ), L. acidophilus , and Bifidobacterium bifidum ( Shandilya et al, 2016 )] facilitate increasing the host sIgA levels and some probiotics [including Bifidobacterium bifidum ( Tanaka et al, 2017 ) and Bacillus subtilis ( Guo et al, 2017 )] contribute to increase the host serum IgG levels. Thus, our findings facilitate our increasing understandings of the regulatory role of probiotics in host immune system.…”
Section: Discussionmentioning
confidence: 99%
“…This study was registered in the UMIN (University Hospital Medical Information Network in Japan) Clinical Trial Registry (UMIN000020520) and was conducted in accordance with the Declaration of Helsinki. We used fecal samples collected for our previously reported study [25] after obtaining written informed consent from the guardians of the infants according to the approval provided by the Institutional Review Board of Shiga University of Medical Science (approval number 24-151), Japan.…”
Section: Methodsmentioning
confidence: 99%
“…The subject and protocol have been described previously [25], and this study is a secondary analysis focusing on bifidobacterial colonization in LBW infants. The subjects of the study were selected from LBW infants (1500–2500 g) who were admitted in the neonatal intensive care unit (NICU) of Shiga University of Medical Science Hospital between March 2013 and May 2014, and whose legal guardians provided written informed consent for participation in the study within 48 h after birth.…”
Section: Methodsmentioning
confidence: 99%